An NK1 receptor antagonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Befetupitant

Item No. 43004

Technical Information
Formal Name
N,α,α-trimethyl-N-[4-(2-methylphenyl)-6-(4-morpholinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-benzeneacetamide
CAS Number
290296-68-3
Synonyms
  • Ro 67-5930
Molecular Formula
C29H29F6N3O2
Formula Weight
Purity
≥98%
A solid
Acetonitrile: Slightly soluble: 0.1-1 mg/mlDMSO: Sparingly soluble: 1-10 mg/ml
SMILES
CC(C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)(C(N(C(C(C2=C(C=CC=C2)C)=C3)=CN=C3N4CCOCC4)C)=O)C
InChi Code
InChI=1S/C29H29F6N3O2/c1-18-7-5-6-8-22(18)23-16-25(38-9-11-40-12-10-38)36-17-24(23)37(4)26(39)27(2,3)19-13-20(28(30,31)32)15-21(14-19)29(33,34)35/h5-8,13-17H,9-12H2,1-4H3
InChi Key
ZGNPLCMMVKCTHM-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Befetupitant is a neurokinin-1 (NK1) receptor antagonist (Ki = 1 nM).1 It inhibits GR73632-induced foot tapping in gerbils (ID50 = 0.2 mg/kg). Topical administration of befetupitant (0.4 or 1.6 mg/ml for four days) decreases hemangiogenesis and lymphangiogenesis but induces corneal opacity, stromal leukocyte infiltration, and corneal toxicity in a mouse model of corneal alkali burn.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hoffmann, T., Bös, M., Stadler, H., et al. Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists. Bioorg. Med. Chem. Lett. 16(5), 1362-1365 (2006).

    2. Bignami, F., Giacomini, C., Lorusso, A., et al. NK1 receptor antagonists as a new treatment for corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 55(10), 6783-6794 (2014).